Cannabis and Alzheimer's: What the Research Actually Says

Research suggests cannabis compounds like THC and CBD could help with Alzheimer's by curbing brain inflammation, acting as antioxidants and, in lab and animal studies, slowing the buildup of amyloid plaques. Alzheimer's is a neurodegenerative disease that mostly affects older adults and slowly erodes memory and other cognitive functions. None of this adds up to a proven treatment yet: most of the evidence comes from cell cultures and animal models, not large human trials.

The cannabinoids are the compounds behind that interest: recent research suggests some of them could offer therapeutic benefits for people living with Alzheimer's.

Cannabinoids like THC and CBD have properties that can influence neurochemical processes in the brain, and some patients and caregivers report they help ease certain symptoms linked to the disease.

Alzheimer's disease and the potential of cannabinoids

Despite major efforts in drug research over the last 30 years, the treatments available for Alzheimer's today offer only limited improvements in cognition and day-to-day function, and none of them stop or reverse the neurodegenerative process.

That reality has fueled an urgent search for more effective therapies for a growing number of patients. Against that backdrop, research is shifting toward new multi-target therapies that can act on several of the disease processes linked to Alzheimer's at once.

Cannabinoids, the compounds found in cannabis, have drawn growing interest because emerging evidence suggests they might improve some Alzheimer's-related symptoms.

The endocannabinoid system and Alzheimer's

The first clues about the therapeutic potential of cannabinoids in Alzheimer's came from studying the endocannabinoid system: the body's own network of receptors, endogenous ligands (the cannabinoids your body makes) and the enzymes that build and break those ligands down.

Pioneering work by Dr. Julián Romero and Dr. María de Ceballos in Madrid found increased expression of the CB2 cannabinoid receptor in microglia, the brain's immune cells, which become activated around the amyloid plaques that are a hallmark of Alzheimer's.

Other studies and animal models backed up those findings. Researchers also saw increased expression of fatty acid amide hydrolase (FAAH), the enzyme that breaks down the body's own cannabinoid anandamide, at the inflammation hot spots around amyloid-beta (Aβ) plaques.

These findings suggest CB2 receptors and FAAH could be promising drug targets for Alzheimer's treatment.

The debate over the CB1 receptor

The role of the CB1 cannabinoid receptor in Alzheimer's, on the other hand, is still up for debate. Some studies point to higher activity of this receptor in the early stages of the disease, followed by a drop in advanced stages, while others have found no significant difference in CB1 levels between the brains of people with Alzheimer's and healthy people.

Still, CB1 remains relevant because of its neuroprotective role and its influence on processes the disease disrupts. A more recent animal study found that removing the CB1 receptor sped up Alzheimer's progression in a mouse model of the disease, underscoring how important it may be in the disease.

This view of cannabinoids' potential in Alzheimer's highlights why it's worth continuing to explore new therapies to improve quality of life for people living with this devastating disease.

How could cannabis help with Alzheimer's?

1. CBD and THC in Alzheimer's prevention and slowing cognitive decline

The biochemistry of human neural networks is incredibly complex and still not fully understood. Even so, keeping brain tissue healthy throughout life may significantly lower the risk of neurodegenerative diseases like Alzheimer's, or at least delay their onset by slowing cognitive decline.

Regular exercise is a cornerstone of brain health, and researchers are also looking at whether outside compounds, like the cannabinoids in cannabis, could play a role in supporting brain chemistry.

Cannabis contains cannabinoids like THC and CBD, which have physiological effects relevant to Alzheimer's. In lab studies, these compounds have shown anti-inflammatory, antioxidant and neuroprotective effects, and some research points to them even stimulating the growth of new neural tissue.

Some researchers have floated the idea that cannabinoids might slow the progression of existing Alzheimer's or even help prevent it, but that hypothesis hasn't been confirmed in human trials.

2. Low-dose THC and amyloid-beta production

Amyloid-beta is a peptide that comes from the breakdown of amyloid precursor protein (APP), and it's involved in forming the toxic amyloid plaques found in the brains of people with Alzheimer's.

A 2014 study by researchers at the University of South Florida found that low doses of THC slowed amyloid-beta production in cell models of the disease.

In that research, THC not only cut down on plaque formation but also lowered levels of glycogen synthase kinase-3 beta (GSK3β), an enzyme that contributes to neurofibrillary tangles, the clumps of tau protein associated with Alzheimer's.

3. Cannabis as an anti-inflammatory

Inflammation in neural tissue plays a key role in the development of Alzheimer's and other neurodegenerative diseases. Chronic inflammation can wear down brain tissue, and studies have shown that the endocannabinoid system helps regulate neuroinflammation.

Research has found changes in endocannabinoid system components in the brains of Alzheimer's patients, including increased cannabinoid receptor expression in microglia.

Cannabis compounds might help keep inflammation in check by acting on these receptors, cutting the production of inflammatory compounds and protecting neural tissue.

4. The antioxidant and neuroprotective properties of medical cannabis

Oxidative stress, caused by free radicals and reactive oxygen species, is a key factor in Alzheimer's. Inflammation triggered by amyloid-beta also feeds into that oxidative stress.

Cannabinoids have shown antioxidant properties that may protect nerve cells from oxidative damage. A 2004 lab study found that cannabidiol (CBD) increased cell survival in the presence of amyloid-beta, pointing to a possible neuroprotective effect of CBD.

5. CBD and neurogenesis

Beyond its anti-inflammatory and antioxidant effects, cannabidiol (CBD) may also stimulate neurogenesis, the process of forming new neural tissue. That's especially relevant for Alzheimer's, where the destruction of neural tissue gets in the way of memory and other cognitive functions.

A 2011 study in an animal model found that CBD could promote neurogenesis in the hippocampus, a key brain region hit by Alzheimer's, by acting on the peroxisome proliferator-activated receptor gamma (PPAR-γ) and blocking the effects of amyloid-beta.

As research on cannabis and Alzheimer's moves forward, the evidence suggests cannabinoids could one day offer meaningful benefits in preventing and treating this devastating disease, but for now it's promising science, not a proven therapy.

As researchers learn more about the endocannabinoid system and its role in brain health, medical cannabis could become a valuable tool for improving quality of life for people affected by Alzheimer's. If someone you love has the disease, talk it through with their doctor before adding cannabis to the mix.